Daniel Donnelly

Merck & Co., Inc.

Daniel Donnelly is a Senior Scientist at Merck & Co. working on the Analytical Research and Development Mass Spec Team. He supports biologic and vaccine development through various MS characterization techniques.

Appearances

Session VII – New Modalities, Technologies, Approaches and Methods
Date
September 17, 2020
Chairs
Da Ren
Amgen Inc.
Christopher Yu
Genentech, a Member of the Roche Group
Speakers
Pavel Bondarenko
Amgen Inc.
Yi Pu
Biogen
Daniel Donnelly
Merck & Co., Inc.
Camille Lombard-Banek
NIST
Jason Rouse
Pfizer, Inc.

Daniel Donnelly

Merck & Co., Inc.

Appearances

Session VII – New Modalities, Technologies, Approaches and Methods

Chairs

Speakers